Volume 54, Issue 1, Pages (July 1998)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Pathophysiology of renal fluid retention

G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth Hai-Chang Huang,

Chronic Pain in End-Stage Renal Disease

Renal Tubular Acidosis and the Nephrology Teaching Paradigm

Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri Kidney International

Role of c-SRC and ERK in acid-induced activation of NHE3

Volume 58, Issue 1, Pages (July 2000)

Volume 83, Issue 3, Pages (March 2013)

Progression of renal failure and hypertensive nephrosclerosis

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Pathophysiology of renal fluid retention

Chronic Pain in End-Stage Renal Disease

Volume 58, Issue 1, Pages (July 2000)

Metformin and other antidiabetic agents in renal failure patients

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Volume 54, Issue 5, Pages (November 1998)

Volume 71, Issue 11, Pages (June 2007)

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra

Volume 76, Issue 6, Pages (September 2009)

A physician's perseverance uncovers problems in a key nephrology study

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Urinary biomarkers: the future looks promising

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Role of c-SRC and ERK in acid-induced activation of NHE3

Methods for guideline development

Volume 76, Issue 1, Pages (July 2009)

Choong Kim, Nosratola D. Vaziri Kidney International

Volume 56, Issue 4, Pages (October 1999)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

A man with a hole in his penis

Volume 73, Issue 9, Pages (May 2008)

Opportunities for a chronic disease outreach program in China

Long-term survival in renal transplant recipients with graft function

The course of the remnant kidney model in mice

Volume 64, Issue 6, Pages (December 2003)

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Nosratola D. Vaziri, M.D., Kaihui Liang Kidney International

Joel Z. Melnick, Patricia A. Preisig, Robert J. Alpern, Michel Baum

Volume 80, Issue 10, Pages (November 2011)

Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity Lorenzo.

Is it the low-protein diet or simply the salt restriction?

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Aldosterone and potassium secretion by the cortical collecting duct

Cell cycle regulation: Repair and regeneration in acute renal failure

Where vaptans do and do not fit in the treatment of hyponatremia

Volume 74, Issue 10, Pages (November 2008)

Ronen Levi, Justin Silver Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 54, Issue 1, Pages 160-165 (July 1998) Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia Joel Z. Melnick, Patricia A. Preisig, Orson W. Moe, Paul Srere, Robert J. Alpern Kidney International Volume 54, Issue 1, Pages 160-165 (July 1998) DOI: 10.1046/j.1523-1755.1998.00974.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Renal cortical m-aconitase activity: Chronic metabolic acidosis. Following treatment, renal cortical mitochondria were isolated and m-aconitase activity measured. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 M-aconitase protein abundance: chronic metabolic acidosis. Following treatment of the animals, renal cortical mitochondria were isolated and m-aconitase protein abundance was measured by Western blot. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Renal cortical m-aconitase activity: K+ deficiency. Following treatment, renal cortical mitochondria were isolated and m-aconitase activity measured. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 M-aconitase protein abundance: Chronic K+ deficiency. Following treatment of the animals, renal cortical mitochondria were isolated and m-aconitase protein abundance was measured by Western blot. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Renal cortical m-aconitase activity: Chronic alkali feeding. Following treatment, renal cortical mitochondria were isolated and m-aconitase activity measured. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 M-aconitase protein abundance: Chronic alkali feeding. Following treatment of the animals, renal cortical mitochondria were isolated and m-aconitase protein abundance was measured by Western blot. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 Hepatic m-aconitase activity in chronic metabolic acidosis, K+ deficiency, and alkali feeding. Following treatment, hepatic mitochondria were isolated and m-aconitase activity measured. Kidney International 1998 54, 160-165DOI: (10.1046/j.1523-1755.1998.00974.x) Copyright © 1998 International Society of Nephrology Terms and Conditions